SARS-CoV-2 variants, spike mutations and immune escape

Cited by (1,002)

Items 701–800 of 1,002

1. The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro
   S. Sonnleitner, S. Sonnleitner, E. Hinterbichler, H. Halbfurter, Dominik B. C. Kopecky, S. Koblmüller, C. Sturmbauer, W. Posch, G. Walder · 2022 · Virologica Sinica
2. AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2
   Marah G. Chibwana, Thandeka Moyo-Gwete, Gaurav Kwatra, Jonathan J. Mandolo, Tandile Hermanaus, Thopisang P. Motlou, Nonkululeko B. Mzindle, Frances Ayres, Mphatso Mayuni Chaponda, Godwin Tembo et al. · 2022 · BMC Medicine
3. Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera
   Yfat Yahalom-Ronen, Noam Erez A, Morly Fisher, Hadas Tamir, Boaz Politi, Hagit Achdout, Sharon Melamed, Itai Glinert, Shay Weiss, Inbar Cohen-Gihon et al. · 2022 · Vaccines
4. Mutations of Omicron Variant at the Interface of the Receptor Domain Motif and Human Angiotensin-Converting Enzyme-2
   Puja Adhikari, Bahaa Jawad, R. Podgornik, Wai-Yim Ching · 2022 · bioRxiv
5. Willingness-to-pay for COVID-19 vaccine in ten low-middle-income countries in Asia, Africa and South America: A cross-sectional study
   Malik Sallam, Samsul Anwar, Amanda Yufika, Marhami Fahriani, Milda Husnah, Hendrix Indra Kusuma, Rawan Raad, Namareg ME. Khiri, Rashed YA. Abdalla, Rashed Y. Adam et al. · 2022 · Narra J
6. SARS-CoV-2 mutations acquired during serial passage in human cell lines are consistent with several of those found in recent natural SARS-CoV-2 variants
   Hoyin Chung, J. Y. Noh, Bon-Sang Koo, J. Hong, Hye Kwon Kim · 2022 · Computational and Structural Biotechnology Journal
7. Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
   Hang Ma, Yingying Guo, Haoneng Tang, Chien-Te Kent Tseng, Lei Wang, Huifang Zong, Zhenyu Wang, Yang He, Yunsong Chang, Shusheng Wang et al. · 2022 · Cell Discovery
8. The ORF8 Protein of SARS-CoV-2 Modulates the Spike Protein and Its Implications in Viral Transmission
   Jen-Mei Chou, Jo-Ling Tsai, Jo-Ning Hung, I-Hua Chen, Szu-Ting Chen, Ming‐Han Tsai · 2022 · Frontiers in Microbiology
9. Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant
   Guilherme Rodrigues Fernandes Campos, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, Camila Amormino Corsini, Sarah Vieira Contin Gomes, Daniel Alvim Pena de Miranda, Jéssica Vieira de Assis, Thaís Bárbara de Souza Silva, Pedro Augusto Alves, Gabriel da Rocha Fernandes et al. · 2022 · Communications Medicine
10. Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients
    Antonio Grimaldi, Francesco Panariello, Patrizia Annunziata, Teresa Giuliano, Michela Daniele, Biancamaria Pierri, Chiara Colantuono, Marcello Salvi, Valentina Bouchè, Anna Manfredi et al. · 2022 · Genome Medicine
11. SARS-CoV-2 immunity and vaccine strategies in people with HIV
    Claire Mullender, Kelly da Costa, Aljawharah Alrubayyi, Sarah Lilian Pett, Dimitra Peppa · 2022 · Oxford Open Immunology
12. Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors
    Payton A. B. Weidenbacher, Eric Waltari, Izumi de los Rios Kobara, Benjamin N. Bell, Mary Kate Morris, Ya-Chen Cheng, Carl Veith Hanson, John E. Pak, Peter S. Kim · 2022 · Nature Chemical Biology
13. De novo selected hACE2 mimics that integrate hotspot peptides with aptameric scaffolds for binding tolerance of SARS-CoV-2 variants
    Minjong Lee, Byunghwa Kang, Juhwa Lee, Jisun Lee, Sang Taek Jung, Chang Yun Son, Seung Soo Oh · 2022 · Science Advances
14. The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages
    Tiandan Xiang, Junzhong Wang, Xin Zheng · 2022 · Virologica Sinica
15. Self-Adjuvanting Protein Vaccine Conjugated with a Novel Synthetic TLR4 Agonist on Virus-Like Liposome Induces Potent Immunity against SARS-CoV-2
    Dong Ding, Yu Wen, Chun-Miao Liao, Xuguang Yin, Ruyan Zhang, Jian Wang, Shihao Zhou, Zhi-Ming Zhang, Yong-Ke Zou, Xiao-Fei Gao et al. · 2023 · Journal of Medicinal Chemistry
16. Biology of the SARS-CoV-2 Coronavirus
    Rimma N. Mingaleeva, Nigina A. Nigmatulina, Liliya M. Sharafetdinova, Albina M. Romozanova, Aida G. Gabdoulkhakova, Филина Юлия Викторовна, Шавалиев Рафаэль Фирнаялович, Albert Anatolyevich Rizvanov, Мифтахова Регина Рифкатовна · 2022 · Biochemistry (Moscow)
17. Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics
    Matteo Pavan, Stefano Moro · 2023 · International Journal of Molecular Sciences
18. Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants
    Haisheng Yu, Banghui Liu, Yudi Zhang, Xijie Gao, Qian Wang, Haitao Xiang, Xiaofang Peng, Caixia Xie, Yaping Wang, Peiyu Hu et al. · 2023 · Nature Communications
19. Functional Foods: A Promising Strategy for Restoring Gut Microbiota Diversity Impacted by SARS-CoV-2 Variants
    Antara Banerjee, Indumathi Somasundaram, Diptimayee Das, Samatha Jain Manoj, Husaina Banu, Pavane Mitta Suresh, Sujay Paul, Atıl Bişgin, Hong Zhang, Xiao‐Feng Sun et al. · 2023 · Nutrients
20. Alkyne as a Latent Warhead to Covalently Target SARS-CoV-2 Main Protease
    Chau Ngo, William Fried, Saba Roghiyh Aliyari, Joshua J. Feng, Chao Qin, Shilei Zhang, Hanjing Yang, Jean Shanaa, Pinghui Feng, Genhong Cheng et al. · 2023 · Journal of Medicinal Chemistry
21. Development of highly sensitive one-step reverse transcription-quantitative PCR for SARS-CoV-2 detection in wastewater
    Sunayana Raya, Bikash Malla, Ocean Thakali, Made Sandhyana Angga, Eiji Haramoto · 2023 · The Science of The Total Environment
22. Lineage replacement and evolution captured by 3 years of the United Kingdom Coronavirus (COVID-19) Infection Survey
    Katrina Lythgoe, Tanya Golubchik, Matthew D. Hall, Thomas House, Roberto Cahuantzi, George MacIntyre-Cockett, Helen R. Fryer, Laura Thomson, Anel Nurtay, Mahan Ghafari et al. · 2023 · Proceedings of the Royal Society B Biological Sciences
23. A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity
    Leire de Campos‐Mata, Benjamin Trinité, Andrea Modrego, Sonia Tejedor Vaquero, Edwards Pradenas, Anna Pons-Grífols, Natalia Rodrigo Melero, Diego Carlero, Sílvia Marfil, César A. Santiago et al. · 2024 · Nature Communications
24. New trends on the systems approach to modeling SARS-CoV-2 pandemics in a globally connected planet
    Giulia Bertaglia, Andrea Bondesan, Diletta Burini, Raluca Eftimie, Lorenzo Pareschi, Giuseppe Toscani · 2024 · Mathematical Models and Methods in Applied Sciences
25. Bacteriophage λ exonuclease and a 5′-phosphorylated DNA guide allow PAM-independent targeting of double-stranded nucleic acids
    Shengnan Fu, Junjie Li, Jing Chen, Linghao Zhang, Jiajia Liu, Huiyu Liu, Xin Su · 2024 · Nature Biotechnology
26. COVID-19 vaccine design and vaccination strategy for emerging variants
    Vivek P. Chavda, Vasso Apostolopoulos · 2022 · Expert Review of Vaccines
27. SARS-CoV-2 and COVID-19: A Narrative Review
    Andrew D. Blann, Rebekka Heitmar · 2022 · British Journal of Biomedical Science
28. A Comprehensive Analysis of Structural and Functional Changes Induced by SARS-CoV-2 Spike Protein Mutations
    Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, Rene Bernadette Khan, Hezekiel Mathambo Kumalo · 2023 · COVID
29. The R203M and D377Y mutations of the nucleocapsid protein promote SARS-CoV-2 infectivity by impairing RIG-I-mediated antiviral signaling
    Yongkui Li, Moran Li, Heng Xiao, Feng Liao, Miaomiao Shen, Wei-Wei Ge, Junxian Ou, Yuqing Liu, Lu-Miao Chen, Yue Zhao et al. · 2025 · PLoS Pathogens
30. Molecular Level Dissection of Critical Spike Mutations in SARS‐CoV‐2 Variants of Concern (VOCs): A Simplified Review
    Nilesh Joshi, Adish Tyagi, Sandeep Nigam · 2021 · ChemistrySelect
31. COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines
    Biswajit Kumar Biswas, Shagnik Chattopadhyay, Sayantee Hazra, Arman Kunwar Hansda, Ritobrata Goswami · 2022 · Inflammation Research
32. Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry
    Norbert Stefan, Katrin Sippel, Martin Heni, Andreas Fritsche, Robert J. Wagner, Carolin E. M. Jakob, Hubert T. Preissl, Alexander von Werder, Yascha Khodamoradi, Stefan Borgmann et al. · 2022 · Frontiers in Medicine
33. SCORe: SARS-CoV-2 Omicron Variant RBD-Binding DNA Aptamer for Multiplexed Rapid Detection and Pseudovirus Neutralization
    Lucy F. Yang, Nataly A. Kacherovsky, Joey Liang, Stephen J. Salipante, Suzie Hwang Pun · 2022 · Analytical Chemistry
34. Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain
    Eleni Pitsillou, Julia J. Liang, Raymond C. Beh, Andrew Hung, Tom C. Karagiannis · 2022 · Computers in Biology and Medicine
35. SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant
    Larissa M. Laine, Marika Skön, Elina Väisänen, Ilkka Julkunen, Pamela Österlund · 2022 · Frontiers in Immunology
36. Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals
    Mariliis Jaago, Annika Rähni, Nadežda Pupina, Arno Pihlak, Helle Sadam, Jürgen Tuvikene, Annela Avarlaid, Anu Planken, Margus Planken, Liina Haring et al. · 2022 · Scientific Reports
37. Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins
    Kyle Lee O’Donnell, Tylisha Gourdine, Paige Fletcher, Chad S. Clancy, Andrea Marzi · 2022 · Frontiers in Immunology
38. Cardiovascular, Pulmonary, and Neuropsychiatric Short- and Long-Term Complications of COVID-19
    Małgorzata Kobusiak−Prokopowicz, Katarzyna Fułek, Michał Fułek, Konrad Kaaz, Andrzej Mysiak, Donata Kurpas, Jan Aleksander Beszłej, Anna Brzecka, Jerzy Leszek · 2022 · Cells
39. Quantitative profiling of N-glycosylation of SARS-CoV-2 spike protein variants
    Yongjing Xie, Michael Butler · 2023 · Glycobiology
40. Coordinated evolution at amino acid sites of SARS-CoV-2 spike
    Alexey D. Neverov, Gennady G. Fedonin, Anfisa V. Popova, Daria Bykova, Georgii A. Bazykin · 2023 · eLife
41. LC-MS/MS-Based Proteomics Approach for the Identification of Candidate Serum Biomarkers in Patients with Narcolepsy Type 1
    Akeem Sanni, Mona Goli, Jingfu Zhao, Junyao Wang, Chloe Barsa, Samer El Hayek, Farid Ramzi Talih, Bartolo Lanuzza, Firas H. Kobeissy, Giuseppe Plazzi et al. · 2023 · Biomolecules
42. Delta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice
    Ju-Hee Yang, Myeon‐Sik Yang, Dae-Min Kim, Bumseok Kim, Dongseob Tark, Sangmin Kang, Gun-Hee Lee · 2023 · Scientific Reports
43. Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: an update
    Adrián Hernández-Díazcouder, César Díaz-Godínez, Julio César Carrero · 2023 · Applied Microbiology and Biotechnology
44. Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development
    Xuemei He, Cai He, Weiqi Hong, H. J. Yang, Xiawei Wei · 2023 · Medicinal Research Reviews
45. Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells
    Alok Kumar Singh, Rulin Wang, Kara A. Lombardo, Monali Praharaj, C. Korin Bullen, Peter K. Um, Manish Gupta, Geetha Srikrishna, S. Lindsey Davis, Oliver D. Komm et al. · 2023 · iScience
46. Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19
    Gang Ye, Ruangang Pan, Fan Bu, Jian Hua Zheng, Alise Mendoza, Wei Wen, Lanying Du, Benjamin W. Spiller, Brian E. Wadzinski, Bin Liu et al. · 2023 · Journal of Virology
47. Virus-mimicking nanosystems: from design to biomedical applications
    Haoyang Liu, Xiao Li, Zhi-Gang Wang, Shu‐Lin Liu · 2023 · Chemical Society Reviews
48. Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans
    David Chmielewski, Eric Wilson, Grigore D Pintilie, Peng Zhao, Muyuan Chen, Michael F. Schmid, Graham Simmons, Lance Wells, Jing Jin, Abhishek Singharoy et al. · 2023 · Nature Communications
49. Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice
    Alexandra Schäfer, David R. Martinez, John J. Won, Fernando R. Moreira, Ariane J. Brown, Kendra L. Gully, Rao V. Kalla, Kwon Chun, Venice Du Pont, Darius M. Babusis et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
50. Close relatives of MERS-CoV in bats use ACE2 as their functional receptors
    Qing Xiong, Lei Cao, Chengbao Ma, Chen Liu, Junyu Si, Peng Liu, Mengxue Gu, Chunli Wang, Lulu Shi, Fei Tong et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
51. Post-Vaccination Neutralization Responses to Omicron Sub-Variants
    Jacobsen, Henning, Katzmarzyk, Maeva, Higdon, Melissa M., Jiménez, Viviana Cobos, Sitaras, Ioannis, Bar-Zeev, Naor, Knoll, Maria Deloria · 2022 · Vaccines
52. SAR, Molecular Docking and Molecular Dynamic Simulation of Natural Inhibitors against SARS-CoV-2 Mpro Spike Protein
    Aqsa Salamat, Naveen Kosar, Ayesha Mohyuddin, Muhammad Imran, Muhammad Nauman Zahid, Tariq Mahmood · 2024 · Molecules
53. Navigating the COVID-19 Therapeutic Landscape: Unveiling Novel Perspectives on FDA-Approved Medications, Vaccination Targets, and Emerging Novel Strategies
    Reham F. Barghash, Donato Gemmati, Ahmed M. Awad, Mustafa Mahmoud Mohamed Elbakry, Veronica Tisato, Kareem Awad, Ajay Vikram Singh · 2024 · Molecules
54. SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
    Fabrizio Angius, Silvia Puxeddu, Silvio Zaimi, Serena Canton, Sepehr Nematollahzadeh, Andrea Pibiri, Ilenia Delogu, Gualtiero Alvisi, Meng Ling Moi, Aldo Manzin · 2024 · Vaccines
55. Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic
    Wilhelm Furnon, Vanessa M. Cowton, Giuditta De Lorenzo, Richard J Orton, Vanessa Herder, Diego M. Cantoni, Georgios Ilia, Diogo Corrêa Mendonça, Karen Kerr, Jay Allan et al. · 2025 · Nature Microbiology
56. Computational decomposition reveals reshaping of the SARS‐CoV‐2–ACE2 interface among viral variants expressing the N501Y mutation
    Eileen Socher, Marcus Conrad, Lukas Heger, Friedrich P. Paulsen, Heinrich Sticht, Friederike Zunke, Philipp Arnold · 2021 · Journal of Cellular Biochemistry
57. Distinct shifts in site-specific glycosylation pattern of SARS-CoV-2 spike proteins associated with arising mutations in the D614G and Alpha variants
    Chu‐Wei Kuo, Tzu‐Jing Yang, Yu-Chun Chien, Pei‐Yu Yu, Shang‐Te Danny Hsu, Kay‐Hooi Khoo · 2021 · Glycobiology
58. Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells
    Gabriel Augusto Pires de Souza, Marion Le Bideau, Céline Boschi, Lorène Ferreira, Nathalie Wurtz, Christian Albert Devaux, Philippe Colson, Bernard La Scola · 2021 · Viruses
59. Comparative characterization of SARS‐CoV‐2 variants of concern and mouse‐adapted strains in mice
    Qi Chen, Xing-Yao Huang, Yu Liu, Meng-Xu Sun, B. Ji, Chao Zhou, Hang Chi, Rong-Rong Zhang, Dan Luo, Ying Tian et al. · 2022 · Journal of Medical Virology
60. Multicenter international assessment of a SARS-CoV-2 RT-LAMP test for point of care clinical application
    Suying Lü, David Duplat, Paula Benitez-Bolivar, Cielo Maritza León, Stephany D. Villota, Eliana Veloz-Villavicencio, Valentina Arévalo, Katariina Jaenes, Yuxiu Guo, Seray Cicek et al. · 2022 · PLoS ONE
61. Complex Mutation Pattern of Omicron BA.2: Evading Antibodies without Losing Receptor Interactions
    Saathvik R. Kannan, Austin N. Spratt, Kalicharan Sharma, Ramesh K. Goyal, Anders B. Sönnerborg, Subbu Apparsundaram, Christian L. Lorson, Siddappa N. Byrareddy, Kamal Singh · 2022 · International Journal of Molecular Sciences
62. Insertion-and-Deletion Mutations between the Genomes of SARS-CoV, SARS-CoV-2, and Bat Coronavirus RaTG13
    Tetsuya Akaishi · 2022 · Microbiology Spectrum
63. Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants
    Hancong Sun, Jinghan Xu, Guanying Zhang, Jin Han, Meng Hao, Zhengshan Chen, Ting Fang, Xiangyang Chi, Changming Yu · 2022 · Viruses
64. Wastewater surveillance allows early detection of SARS-CoV-2 omicron in North Rhine-Westphalia, Germany
    Alexander Wilhelm, Jens Schoth, Christina Meinert‐Berning, Shelesh Agrawal, Daniel Bastian, Laura Orschler, Sandra Ciesek, Burkhard Teichgräber, Thomas Wintgens, Susanne Lackner et al. · 2022 · The Science of The Total Environment
65. IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
    Matthew Chang, Luke M. Tomasovic, Natalia A. Kuzmina, Adam J. Ronk, Patrick O. Byrne, Rebecca I. Johnson, Nadia Storm, Eduardo Olmedillas, Yixuan Jacob Hou, Alexandra Schäfer et al. · 2022 · Nature Communications
66. Multi-Omics Reveals Mechanisms of Partial Modulation of COVID-19 Dysregulation by Glucocorticoid Treatment
    Matt P. Spick, Amy E. Campbell, Ivona Baričević-Jones, Johanna von Gerichten, Holly-May Lewis, Cécile Frampas, Katie Longman, Alexander Stewart, Deborah K. Dunn‐Walters, Debra Jean Skene et al. · 2022 · International Journal of Molecular Sciences
67. COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies
    Jilian Dong, Ruida Chen, Hanhe Zhao, Yirui Zhu · 2022 · Advances in Ophthalmology Practice and Research
68. Comorbidities prolonged viral shedding of patients infected with SARS-CoV-2 omicron variant in Shanghai: A multi-center, retrospective, observational study
    Lei Pei, Ying Chen, Xiangtao Zheng, Fangchen Gong, Wenbin Liu, Jingsheng Lin, Ruizhi Zheng, Zhitao Yang, Yufang Bi, Erzhen Chen · 2022 · Journal of Infection and Public Health
69. Therapeutic potential of salicylamide derivatives for combating viral infections
    Jimin Xu, Yu Xue, Andrew A. Bolinger, Jun Li, Mingxiang Zhou, Haiying Chen, Hongmin Li, Jia Zhou · 2023 · Medicinal Research Reviews
70. Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: a longitudinal cohort study
    Anthony Ravussin, Anna Hayman Robertson, Asia‐Sophia Wolf, Kristine Blix, Ingrid Fadum Kjønstad, Guri Solum, Berit Feiring, Bjørn Heine Strand, Fridtjof Lund‐Johansen, Ludvig A. Munthe et al. · 2023 · The Lancet Healthy Longevity
71. Human Genomics of COVID-19 Pneumonia: Contributions of Rare and Common Variants
    Aurélie Cobat, Qian Zhang, COVID Human Genetic Effort, Laurent Abel, Jean‐Laurent Casanova, Jacques Fellay · 2023 · Annual Review of Biomedical Data Science
72. Multi-omics for COVID-19: driving development of therapeutics and vaccines
    Mengyu Guo, Muya Xiong, Jinying Peng, Tong Guan, Haixia Su, Yanyi Huang, Cai‐Guang Yang, Yang Li, Diana Boraschi, Thanigaimalai Pillaiyar et al. · 2023 · National Science Review
73. Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity
    Muhammad Shuaib, Sabir Abdu Adroub, Tobias Mourier, Sara Mfarrej, Huoming Zhang, Luke E. Esau, Afrah Alsomali, Fadwa S. Alofi, Adeel Nazir Ahmad, Abbas Shamsan et al. · 2023 · Genome Medicine
74. Comparative study between antiviral drugs and natural compounds against “Cryo-EM structure of the SARS-CoV-2 Omicron spike”
    Adarsh Kumar Shukla, Ashwani Kumar · 2023 · Vegetos
75. Single-molecule force stability of the SARS-CoV-2–ACE2 interface in variants-of-concern
    Magnus S. Bauer, Sophia Gruber, Adina Hausch, Marcelo C. R. Melo, Priscila da Silva Figueiredo Celestino Gomes, Thomas Nicolaus, Lukas F. Milles, Hermann E. Gaub, Rafael C. Bernardi, Jan Lipfert · 2023 · Nature Nanotechnology
76. SARS-CoV-2 mechanisms of cell tropism in various organs considering host factors
    Emad Behboudi, Seyed Nooreddin Faraji, Gholamreza Daryabor, Seyed Mohammad Ali Hashemi, Maryam Asadi, Fahime Edalat, Mohammad Javad Raee, Gholamreza Hatam · 2024 · Heliyon
77. Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors
    Valery A. Petrenko, James W. Gillespie, Laura Maria De Plano, Michael Shokhen · 2022 · Viruses
78. A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
    Shan, Sisi, Mok, Chee Keng, Zhang, Shuyuan, Lan, Jun, Li, Jizhou, Yang, Ziqing, Wang, Ruoke, Cheng, Lin, Fang, Mengqi, Aw, Zhen Qin et al. · 2021 · Frontiers in Immunology
79. Indigenous Knowledge and Phytochemistry: Deciphering the Healing Power of Herbal Medicine
    Daniel Etim Jacob, Sylvester Chibueze Izah, Imaobong Ufot Nеlson, Koko Sunday Daniel · 2024 · Reference series in phytochemistry
80. CAR-NK cell therapy: a potential antiviral platform
    Ming-Hao Lin, Lijuan Hu, Jeffrey S. Miller, Xiao‐Jun Huang, Xiang-Yu Zhao · 2025 · 中国科学通报：英文版
81. Neutralizing antibody levels as a key factor in determining the immunogenic efficacy of the novel PEDV alpha coronavirus vaccine
    Guangli Hu, Xin Luo, Jiamin Liao, Chuangchao Zou, Yihui Huang, Rui Geng, Zhiqing Zhao, Hanqin Shen, Yongchang Cao, Ouyang Peng et al. · 2025 · Veterinary Quarterly
82. Fabrication of chitosan-coated mixed spinel ferrite integrated with graphene oxide (GO) for magnetic extraction of viral RNA for potential detection of SARS-CoV-2
    Vijay Kumar Singh, Khalid Mujasam Batoo, Mahavir Singh · 2021 · Applied Physics A
83. SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021
    Ae Kyung Park, Il‐Hwan Kim, Heui Man Kim, Hyeokjin Lee, Nam‐Joo Lee, Jeong‐Ah Kim, SangHee Woo, Chae Young Lee, Jaehee Lee, Sae Jin Oh et al. · 2022 · Emerging infectious diseases
84. Low Neutralizing Antibody Titers against the Mu Variant of SARS-CoV-2 in 31 BNT162b2 Vaccinated Individuals in Colombia
    Diego Alejandro Álvarez-Díaz, Ana Luisa Muñoz, Pilar Tavera-Rodríguez, María T. Herrera-Sepúlveda, Héctor Alejandro Ruiz-Moreno, Katherine Laiton‐Donato, Carlos Franco-Muñoz, Dioselina Peláez‐Carvajal, Diego Cuellar, Alejandra M. Muñoz-Suarez et al. · 2022 · Vaccines
85. A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry
    Jennifer G. Whisenant, Javier Baena, Alessio Cortellini, Li‐Ching Huang, Giuseppe Lo Russo, Luca Porcu, Selina K. Wong, Christine M. Bestvina, Matthew David Hellmann, Elisa Roca et al. · 2022 · Journal of Thoracic Oncology
86. Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding
    Marine E. Bozdaganyan, Olga S. Sokolova, К. В. Шайтан, Mikhail P. Kirpichnikov, Philipp S. Orekhov · 2022 · Viruses
87. Probing marine brown macroalgal phlorotannins as antiviral candidate against SARS-CoV-2: molecular docking and dynamics simulation approach
    Sathaiah Gunaseelan, Malaisamy Arunkumar, Manikka Kubendran Aravind, Santhalingam Gayathri, Senthil Rajkeerthana, Verma Mohankumar, Balasubramaniem Ashokkumar, Perumal Varalakshmi · 2022 · Molecular Diversity
88. AI-powered drug repurposing for developing COVID-19 treatments
    Zhichao Liu, Xi Chen, Wendy Carter, Alicia Moruf, Takashi E. Komatsu, Sonia Pahwa, Kirk M. Chan‐Tack, Kevin Snyder, Nicholas Petrick, Kenny Cha et al. · 2022 · Elsevier eBooks
89. Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern
    Tian-Hong Xie, Shuai-Yao Lu, Zhan-Long He, Hong-Qi Liu, Jun-Bin Wang, Cong Tang, Ting Yang, Wen-Hai Yu, Hua Li, Yun Yang et al. · 2022 · Signal Transduction and Targeted Therapy
90. Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
    Amirmasoud Rayati Damavandi, Razieh Dowran, Sarah Al Sharif, Fatah Kashanchi, Reza Jafari · 2022 · Medical Microbiology and Immunology
91. Fast detection of SARS-CoV-2 variants including Omicron using one-step RT-PCR and Sanger sequencing
    Mandy Bloemen, Annabel Rector, Jill Swinnen, Marc A. Van Ranst, Piet Maes, Bert Vanmechelen, Elke Wollants · 2022 · Journal of Virological Methods
92. Inferring transmission fitness advantage of SARS-CoV-2 variants of concern from wastewater samples using digital PCR, Switzerland, December 2020 through March 2021
    Lea Caduff, David Dreifuss, Tobias Schindler, Alexander J. Devaux, Pravin Ganesanandamoorthy, Anina Kull, Elyse N. Stachler, Xavier Fernández-Cassi, Niko Beerenwinkel, Tamar Kohn et al. · 2022 · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
93. Emergence and spread of a sub-lineage of SARS-CoV-2 Alpha variant B.1.1.7 in Europe, and with further evolution of spike mutation accumulations shared with the Beta and Gamma variants
    Marlena Stadtmüller, Alexa Laubner, Fabian Rost, Sylke Winkler, Eva Patrasová, Lenka Šimůnková, Susanne Reinhardt, Johanna Beil, Alexander H. Dalpke, Buqing Yi · 2022 · Virus Evolution
94. Where is the next SARS-CoV-2 variant of concern?
    John J. Dennehy, Ravindra K. Gupta, William Paul Hanage, Marc C. Johnson, Thomas P. Peacock · 2022 · The Lancet
95. Mutational analysis of SARS-CoV-2 variants of concern reveals key tradeoffs between receptor affinity and antibody escape
    Emily K. Makowski, John S. Schardt, Matthew D. Smith, Peter M. Tessier · 2022 · PLoS Computational Biology
96. Coronaviral Infection and Interferon Response: The Virus-Host Arms Race and COVID-19
    Qi Liu, Sensen Chi, Kostyantyn V. Dmytruk, Olena V. Dmytruk, Shuai Tan · 2022 · Viruses
97. In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2
    Rajkumar Chakraborty, Gourab Bhattacharje, Joydeep Baral, Bharat Manna, Jayati Mullick, Basavaraj Mathapati, Priya Abraham, Jayaprakasam Madhumathi, Yasha Hasija, Amit Ghosh et al. · 2022 · Computers in Biology and Medicine
98. Long-COVID in immunocompromised children
    Karolina Kuczborska, Piotr Buda, Janusz Książyk · 2022 · European Journal of Pediatrics
99. Continent-wide evolutionary trends of emerging SARS-CoV-2 variants: dynamic profiles from Alpha to Omicron
    Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, Kuldeep Dhama, Sang‐Soo Lee · 2022 · GeroScience
100. An Ultrasensitive, One-Pot RNA Detection Method Based on Rationally Engineered Cas9 Nickase-Assisted Isothermal Amplification Reaction
     Ting Wang, Yan Wang, Pinru Chen, Bin‐Cheng Yin, Bang‐Ce Ye · 2022 · Analytical Chemistry